Parag Khanna, AlphaGeo CEO, discusses what technological disruption, economic shifts and migration patterns mean for global supply chains and businesses at large, what lies ahead from an Asian viewpoint and how firms can lead through risk while maximizing opportunity. ...

Supply Chain Vulnerability & Geopolitical Risks - The industry acknowledges the fragility of global supply chains, particularly concerning reliance on China and Russia [2][3][4] - China's use of export controls on critical minerals like rare earths, gallium, and antimony poses a coercive threat to the United States [3] - Russia's actions regarding uranium stocks also present a potential risk to the US [3] Reshoring & Domestic Manufacturing - Major drug manufacturers have announced multi-billion dollar investments to build manufacturing facilities in the US [5] - The administration supports incentivizing domestic manufacturing through measures like tax incentives [5] - An executive order aims to establish price floors through long-term demand contracts, similar to the strategy used with rare earths, to protect domestic producers from unfair dumping by foreign countries [7] Tariffs & Trade Policy - Concerns exist that tariffs may raise costs for drug manufacturers and hinder their ability to profitably establish domestic production [6] - The executive order seeks to counter the practice of foreign countries, particularly China and India, dumping capacity product into US markets [7] Government Intervention & Emergency Response - The government demonstrated the ability to rapidly establish domestic production capabilities during the pandemic, such as ventilator factories in 14 days [9] - The administration emphasizes the importance of protecting American manufacturers [9]